The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Spatial Genomics And Transcriptomics Market In 2026 And 2030?
The spatial genomics and transcriptomics market has seen its size increase rapidly in recent years. This market is projected to expand from $1.7 billion in 2025 to $1.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.4%. The historical growth witnessed in this sector is attributable to advancements in genomics, an increase in transcriptomics research, the discovery of oncology biomarkers, a reduction in sequencing costs, and enhanced research funding.
The spatial genomics and transcriptomics market size is projected for substantial expansion over the upcoming years. This market is anticipated to reach $3.02 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.1%. Factors contributing to this growth during the forecast period include the increasing demand for personalized oncology, advancements in drug discovery applications, the expansion of single-cell analysis, growth in computational biology, and a greater emphasis on clinical translation. Key trends anticipated for the forecast period encompass the proliferation of spatial mapping technologies, the incorporation of AI analytics, a surge in oncology research adoption, the broadening of academic collaborations, and heightened pharmaceutical investment.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24405&type=smp
What Primary Drivers Are Shaping The Spatial Genomics And Transcriptomics Market?
The rising acceptance of personalized medicine is projected to stimulate the expansion of the spatial genomics and transcriptomics market in the foreseeable future. Personalized medicine represents a healthcare strategy that customizes treatment plans for individual patients by considering their genetic makeup, lifestyle, and environmental factors, with the aim of boosting treatment efficacy and minimizing adverse reactions. The escalating demand for personalized medicine is attributed to breakthroughs in genetic research, which facilitate more precise treatments tailored to an individual’s unique genetic profile, leading to enhanced patient outcomes. Spatial genomics and transcriptomics are instrumental in enabling personalized medicine by pinpointing the exact location and activity of genes within tissues, thereby facilitating targeted, individualized treatment strategies based on a patient’s unique molecular landscape. For instance, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit organization, the FDA sanctioned 16 new personalized treatments for patients with rare diseases in 2023, representing a notable increase from the six approvals in 2022. Consequently, the growing adoption of personalized medicine is propelling the growth of the spatial genomics and transcriptomics market.
What Segment Categories Shape The Spatial Genomics And Transcriptomics Market Segment Landscape?
The spatial genomics and transcriptomics market covered in this report is segmented –
1) By Product: Instruments, Consumables, Software
2) By Technology: Spatial Transcriptomics, Sequencing-Based Methods, Immunohistochemistry (IHC), Microscopy-Based RNA Imaging Techniques, Spatial Genomics
3) By Application: Diagnostics, Translation Research, Drug Discovery And Development, Single Cell Analysis, Cell Biology, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes
Subsegments:
1) By Instruments: Sequencing Platforms, Imaging Systems, Fluorescence Microscopes, Slide Scanners, Flow Cytometers
2) By Consumables: Reagents And Kits, Slides And Coverslips, Probes And Tags, Sample Preparation Consumables
3) By Software: Data Analysis And Visualization Tools, Image Analysis Software, Workflow Management Software, Cloud-Based Analytics Platforms
What Trends Are Affecting The Growth Of The Spatial Genomics And Transcriptomics Market?
Major companies in the spatial genomics and transcriptomics market are focusing on developing innovative solutions, such as spatial transcriptomics technologies, to enhance understanding of gene expression within the context of tissue architecture. Spatial transcriptomics technologies refer to advanced techniques that map gene expression across tissue samples while preserving their spatial context, enabling researchers to study the location and distribution of RNA molecules within tissues. For instance, in February 2025, Illumina Inc., a US-based biotechnology company, introduced a pioneering spatial transcriptomics technology that significantly advances the ability to map and analyze gene expression within complex tissues at cellular resolution. Offering a capture area nine times larger and four times higher resolution than existing methods, it enables unbiased, whole-transcriptome profiling with high sensitivity. Compatible with Illumina’s NextSeq and NovaSeq sequencers and integrated into the Illumina Connected Multiomics platform, this technology facilitates comprehensive multiomic data analysis.
Who Are The Companies Operating Across The Spatial Genomics And Transcriptomics Market Value Chain?
Major companies operating in the spatial genomics and transcriptomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Bio-Techne Corporation, 10x Genomics Inc., Standard BioTools Inc., Akoya Biosciences Inc., Seven Bridges Genomics, Vizgen Inc., Lunaphore Technologies SA., Parse Biosciences, Indica Labs Inc., Resolve Biosciences GmbH., RareCyte Inc., Ionpath Inc., Dovetail Genomics, S2 Genomics Inc., BioSpyder Technologies Inc.
Get The Full Spatial Genomics And Transcriptomics Market Report:
Which Region Accounts For The Largest Portion Of The Spatial Genomics And Transcriptomics Market?
North America was the largest region in the spatial genomics and transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spatial genomics and transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Spatial Genomics And Transcriptomics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Spatial Genomics And Transcriptomics Market 2026, By The Business Research Company
Rna Analysis Transcriptomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
Plant Genomics Market Report
https://www.thebusinessresearchcompany.com/report/plant-genomics-global-market-report
Optical Genome Mapping Market Report
https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model